The Correlation of MTHFR SNPs, Homocysteine, and Conventional Risk Predictors with Coronary Artery Disease

[11] Mustafa H.(2006)Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease Chin. Med. J. 119 1871-1011

[12] Ma L.(2018)Significance of asymptomatic hyperuricemia in patients after coronary events Scand. J. Clin. Lab. Invest. 78 312-22

[13] Chandel N.(2019)Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial J. Int. Med. 285 232-213

[14] Ermel R.(2019)Metabolomics study in severe extracranial carotid artery stenosis BMC Neurol. 19 138-206

[15] Piatek J.(2020)Coronary plaque tissue characterization in patients with premature coronary artery disease Int. J. Cardiovasc. Imaging 36 1003-534

[16] Kedziora A.(2020)Plasma homocysteine in patients with coronary and carotid artery disease: a case control study, Odd. Biol. Med. Nauki 41 15-131

[17] Kielbasa R.(2005)Prevalence of genetic risk factors for coronary artery disease in Corsica Island (France) Exp. Mol. Pathol. 79 210-1014

[18] Tay S.Y.(2006)Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease Ann. Clin. Biochem. 43 200-BC08

[19] Chang P.Y.(2003)Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677→ T transition in the MTHFR gene Acta Biochim. Pol. 50 527-353

[20] Lao W.T.,(2009)Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians Clin. Chim. Acta 405 127-637

[11] Mustafa H.(2006)Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease Chin. Med. J. 119 1871-1011

[12] Ma L.(2018)Significance of asymptomatic hyperuricemia in patients after coronary events Scand. J. Clin. Lab. Invest. 78 312-22

[13] Chandel N.(2019)Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial J. Int. Med. 285 232-213

[14] Ermel R.(2019)Metabolomics study in severe extracranial carotid artery stenosis BMC Neurol. 19 138-206

[15] Piatek J.(2020)Coronary plaque tissue characterization in patients with premature coronary artery disease Int. J. Cardiovasc. Imaging 36 1003-534

[16] Kedziora A.(2020)Plasma homocysteine in patients with coronary and carotid artery disease: a case control study, Odd. Biol. Med. Nauki 41 15-131

[17] Kielbasa R.(2005)Prevalence of genetic risk factors for coronary artery disease in Corsica Island (France) Exp. Mol. Pathol. 79 210-1014

[18] Tay S.Y.(2006)Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease Ann. Clin. Biochem. 43 200-BC08

[19] Chang P.Y.(2003)Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677→ T transition in the MTHFR gene Acta Biochim. Pol. 50 527-353

[20] Lao W.T.,(2009)Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians Clin. Chim. Acta 405 127-637